Inside the Utah company aiming to fuel nuclear medicine cancer treatments

by · KSL.com

KEY TAKEAWAYS

  • Nusano, a Utah-based company, aims to address radioisotope shortages in nuclear medicine.
  • Using patented particle accelerator technology, Nusano says it plans to produce 25 different medical isotopes, including those used in cancer treatment.
  • Utah's location offers logistical advantages for quick isotope distribution across the country.

SALT LAKE CITY — Nuclear medicine supports some of the most advanced cancer treatments in the world. The radioisotopes that power it, however, are difficult to produce and often in short supply, which means treatment plans can depend on providers' ability to access the right radioactive materials in time.

One Utah company is working to change that.

"There is an incredible shortage of radioisotopes for clinicians and hospitals and drug treatment companies for the production and the development of treatments and cures for cancer," said Keith Titus, interim CEO at Nusano.

A set of Nusano-branded construction hats and lab passes is pictured at the company's headquarters in West Valley City on June 19, 2026.Lorien Briscoe, KSL

Nuclear medicine uses radioisotopes — unstable versions of chemical elements that release energy as radiation — to help doctors visualize tumors, support research and deliver targeted radiation therapy designed to destroy cancer cells while minimizing damage to healthy tissue. Over 50 million nuclear medicine procedures are performed each year, according to the World Nuclear Association, and demand for radioisotopes continues to increase.

"It's like everyone wants to bake a cake at once, but there's only one cup of flour," said Scott Larrivee, head of Nusano communications.

As demand for nuclear medicine grows, Larrivee said expanding isotope production is critical to keeping pace with cancer research and treatment needs. That is where the Utah-based physics company said it comes in.

Using patented particle acceleration technology, Nusano says it's developing radioisotopes more quickly and efficiently to help close the supply gap. The company is nearing completion of a linear accelerator — a machine that speeds up particles and directs them at specific materials — along with a distribution platform that holds 12 targets and four particle beams used to produce isotopes.

The high energy beam transport (HEBT) is the section of the accelerator that transports the beam from the exit of the drift tube linac (DTL) to the target bays. A careful arrangement of electromagnets – dipoles, quadrupoles, and octupoles – allow Nusano to steer, focus, and shape the beam. The beam travels through a vacuum pipe to one of four target bays, each housing three distinct target stations. This configuration allows Nusano to produce up to 12 isotopes simultaneously by sending beam pulses to the different target stations, each containing a different target.Nusano

Titus and Larrivee said the technology will allow their company to manufacture 25 different isotopes for treatment options, including those used in cancer care. The volume enabled by the four beam lines and 12 targets could help increase availability and reduce costs for patients.

"One of the biggest challenges that all clinicians, hospitals, researchers have is the radioisotope supply availability to do that work," Titus said.

He said Nusano chose Utah for several reasons, including access to talent, a strong workforce and a business-friendly environment.

"First and foremost, access to incredible talent. It is a very business-friendly state. We have a great state government that has been phenomenal to work with," Titus said. "Not just technical expertise, but work ethic. We have a great collaborative team here that we've been able to assemble. Quality of life is exceptional."

"It's attractive," he added.

Utah's location was also important because many radioisotopes have a short half-life, Titus said, meaning they must be shipped quickly to drug production companies across the country. He said having the Delta Airlines hub, FedEx hub and Salt Lake City International Airport close together makes Utah a strong location for that work.

"We all have a family member that we care about or a friend that we care about that has been affected by cancer in their life," Titus said. "And that mission is what connects all of us together."

Larrivee returned to the flour analogy to describe how he and Titus see the company's role in the fight against cancer:

"Think about a giant flour mill," he said. "And then the drug makers and the researchers are the ones that are going to figure out whether they take that flour and it becomes a cake or a pie — all different ways of treating cancer. But without this critical ingredient, they can't do their work."

Photos

Nusano headquarters in West Valley City on June 19.Lórien Briscoe, KSL
After its acceleration in the RFQ, the beam of heavy particles reaches the drift tube linac (DTL), where it continues its journey. The DTL increases the beam’s speed (and energy) using a time-varying electric field. Inside the structure, ions are “pushed” at just the right moment. Hollow metal cylinders, called drift tubes, shield the accelerating particles from the non-accelerating portion of the electric field. Tucked inside each tube is a magnetic lens, a quadrupole, which keeps the beam focused. DTL technology has stood the test of time since the 1940s and remains a reliable backbone of particle accelerators.Nusano
The high energy beam transport (HEBT) is the section of the accelerator that transports the beam from the exit of the drift tube linac (DTL) to the target bays. A careful arrangement of electromagnets – dipoles, quadrupoles, and octupoles – allow Nusano to steer, focus, and shape the beam. The beam travels through a vacuum pipe to one of four target bays, each housing three distinct target stations. This configuration allows Nusano to produce up to 12 isotopes simultaneously by sending beam pulses to the different target stations, each containing a different target.Nusano
The Nusano ion source was tested in the company’s Valencia, California Technology Development Center, prior to transportation to Utah in January 2026 for installation at the company’s radioisotope production facility.Nusano
The low-energy beam transport region of the accelerator is located between the ion source and the radiofrequency quadrupole. The low-energy beam transport line transports the ion beam from the source to the RFQ, while also filtering, characterizing, and optimizing the beam distribution.Nusano
The Low Energy Beam Transport (LEBT) region of the accelerator is located between the ion source and the radiofrequency quadrupole (RFQ). The LEBT line transports the ion beam from the source to the RFQ, while also filtering, characterizing, and optimizing the beam distribution.Nusano
Looking through the interior of the RFQ structure, the route heavy ions will flow through Nusano’s linear accelerator.Nusano
A rendering depicts the view from inside the beam chamber, accelerated particles flow toward a square target. When they collide with the target material, a radioisotope is created.Nusano

The Key Takeaways for this article were generated with the assistance of large language models and reviewed by our editorial team. The article, itself, is solely human-written.

Related topics

Utah TechUtahScienceHealthBusiness
Lórien Briscoe